Rocket Companies heads into the final days of May with two things moving in the same direction: short interest keeps rising and options traders are growing more cautious — yet the borrow market remains wide open, keeping squeeze risk firmly off the table.
Short interest has now reached 9.0% of free float, up 7% on the week and 37% over the past month. That build was reported yesterday as a multi-week high, and it has continued since. From roughly 51 million shares short in early April, the position has grown to 87 million shares — a near-doubling in six weeks. The stock has lost 14% this week alone, closing at $12.67, and is down 24% over the past month. Bears and price action are moving in lockstep.
Options positioning has turned meaningfully more defensive over the week. The put/call ratio hit 0.35, more than 2.7 standard deviations above its 20-day average of 0.29 — the most elevated defensive reading in the period. That's a notable shift from mid-April, when the PCR was running near 0.27. It doesn't yet approach the 52-week high of 0.71, but the direction of travel is clear. Taken together with the short interest build, the positioning picture describes investors actively hedging against further downside rather than leaning into recovery.
The borrow market, however, tells a different story. Availability remains extremely loose at 787% — meaning roughly eight shares are still available to borrow for every one already borrowed. Cost to borrow is 0.41%, unchanged in character despite the short build. There is no sign of borrow scarcity or squeeze pressure. The short build is happening in a liquid lending environment, which suggests bears are building conviction through cheap, accessible channels rather than scrambling for hard-to-find stock.
The Street is cautiously constructive but trimming. The consensus rating is hold, with 3 outperform ratings against 7 holds. Keefe, Bruyette & Woods trimmed its target to $21 from $22 on May 12 while maintaining Outperform. RBC held at $20 Sector Perform. The cluster of targets — $16.50 to $22.50 — sits well above the current $12.67 price, implying significant implied return potential in analyst models, but those models appear to be lagging the stock's deterioration. In early April, JP Morgan cut from $24 to $16.50 and Wells Fargo from $19 to $17 — both moves that now look prescient. The bull case centres on RKT's position as the largest US mortgage originator and the strategic logic of the Mr. Cooper acquisition; the bear case flags integration risk, rate headwinds, and a downside target of $14 that the stock is now approaching. The P/E has compressed to 14.5x and P/B to 1.4x — the 30-day moves of roughly -6x and -0.5x respectively suggesting a meaningful valuation de-rating is already underway. Forward EPS growth expectations remain elevated (ranked 81st percentile), creating a tension between analyst earnings optimism and the price action.
Institutional holders offer some context on ownership. Vanguard, BlackRock, and Fidelity (FMR) are among the largest holders, with Fidelity adding over 10 million shares in Q1. JP Morgan Asset Management added 5 million shares through April, and Jane Street built an 8.6 million share position. Marshall Wace — a long/short fund — added 3.8 million shares in Q1. On the insider side, every disclosed trade in the 90-day window has been a sale. The CTO sold $739,000 of stock on May 6. The CEO sold $871,000 in March. In aggregate, insiders have been net sellers of roughly $30 million in value over 90 days. The sales are modest in the context of overall share counts, but the absence of any buying is notable alongside a stock trading near multi-year lows.
With the next earnings event scheduled for June 10, the setup heading into that print is one to watch: short interest at a six-week high, options more defensive than at any point in the recent trend, and analyst targets still sitting materially above a stock that has compressed nearly 25% in a month.
See the live data behind this article on ORTEX.
Open RKT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
